Inflammation in Hypervolemic Hemodialysis Patients: The Roles of RelB and Caspase-4.
HD
RelA
RelB
caspase-4
endotoxin
hypervolemia
inflammation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
16 Dec 2023
16 Dec 2023
Historique:
received:
09
11
2023
revised:
05
12
2023
accepted:
13
12
2023
medline:
23
12
2023
pubmed:
23
12
2023
entrez:
23
12
2023
Statut:
epublish
Résumé
Hypervolemia is associated with inflammation in hemodialysis (HD) patients. How hypervolemia triggers inflammation is not entirely known. We initiated a cross-sectional study enrolling 40 hemodialysis patients who were categorized into normovolemic (N; 23) and hypervolemic (H; 17) groups by bioimpedance measurement. A caspase activity assay in combination with a specific caspase-4 inhibitor was used to detect caspase-4 activity in isolated peripheral blood mononuclear cells (PBMCs). Transcription factors RelA (pS529) and RelB (pS552) were analyzed by phospho-flow cytometry. Serum endotoxins were detected by an amebocyte lysate-based assay, and
Identifiants
pubmed: 38139378
pii: ijms242417550
doi: 10.3390/ijms242417550
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM